{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:57:32Z","timestamp":1793055452374,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T00:00:00Z","timestamp":1338422400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The objective of this systematic review was to examine the benefits, harms and pharmacokinetic interactions arising from the co-administration of commonly used dietary supplements with cardiovascular drugs. Many patients on cardiovascular drugs take dietary supplements for presumed benefits and may be at risk for adverse supplement-drug interactions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The Allied and Complementary Medicine Database, the Cochrane Library, EMBASE, International Bibliographic Information on Dietary Supplements and MEDLINE were searched from the inception of the review to October 2011. Grey literature was also reviewed.<\/jats:p>\n            <jats:p>Two reviewers independently screened records to identify studies comparing a supplement plus cardiovascular drug(s) with the drug(s) alone. Reviewers extracted data using standardized forms, assessed the study risk of bias, graded the strength of evidence and reported applicability.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Evidence was obtained from 65 randomized clinical trials, 2 controlled clinical trials and 1 observational study. With only a few small studies available per supplement, evidence was insufficient for all predefined gradable clinical efficacy and harms outcomes, such as mortality and serious adverse events. One long-term pragmatic trial showed no benefit from co-administering vitamin E with aspirin on a composite cardiovascular outcome. Evidence for most intermediate outcomes was insufficient or of low strength, suggesting no effect. Incremental benefits were noted for triglyceridemia with omega-3 fatty acid added to statins; and there was an improvement in levels of high-density lipoprotein cholesterol with garlic supplementation when people also consumed nitrates<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Evidence of low-strength indicates benefits of omega-3 fatty acids (plus statin, or calcium channel blockers and antiplatelets) and garlic (plus nitrates or warfarin) on triglycerides and HDL-C, respectively. Safety concerns, however, persist.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/2046-4053-1-26","type":"journal-article","created":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T17:14:13Z","timestamp":1357146853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review"],"prefix":"10.1186","volume":"1","author":[{"given":"Salmaan","family":"Kanji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dugald","family":"Seely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tetzlaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tsertsvadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C","family":"Tricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teik C","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A","family":"Turek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky","family":"Skidmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed T","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,31]]},"reference":[{"key":"45_CR1","first-page":"e46","volume":"121","author":"D Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, de Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P: Heart disease and stroke statistics\u20132010 update: a report from the American Heart Association. Circ Cardiovasc Qual Outcomes. 2010, 121: e46-e215.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"45_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrcardio.2011.2","volume":"8","author":"A Brautbar","year":"2011","unstructured":"Brautbar A, Ballantyne CM: Pharmacological strategies for lowering LDL cholesterol: statins and beyond. Nat Rev Cardiol. 2011, 8: 253-265.","journal-title":"Nat Rev Cardiol"},{"key":"45_CR3","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.jacc.2008.08.039","volume":"52","author":"EJ Mills","year":"2008","unstructured":"Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D: Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008, 52: 1769-1781.","journal-title":"J Am Coll Cardiol"},{"key":"45_CR4","first-page":"814","volume":"171","author":"NK Choudhry","year":"2011","unstructured":"Choudhry NK, Fischer MA, Avorn J, Liberman JN, Schneeweiss S, Pakes J, Brennan TA, Shrank WH: The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011, 171: 814-822.","journal-title":"Arch Intern Med"},{"key":"45_CR5","first-page":"1","volume":"2009","author":"RL Nahin","year":"2007","unstructured":"Nahin RL, Barnes PM, Stussman BJ, Bloom B: Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States. Natl Health Stat Report. 2007, 2009: 1-14.","journal-title":"Natl Health Stat Report"},{"key":"45_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.amjcard.2006.03.051","volume":"98","author":"GY Yeh","year":"2006","unstructured":"Yeh GY, Davis RB, Phillips RS: Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol. 2006, 98: 673-680.","journal-title":"Am J Cardiol"},{"key":"45_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.cardfail.2005.06.427","volume":"11","author":"SM Zick","year":"2005","unstructured":"Zick SM, Blume A, Aaronson KD: The prevalence and pattern of complementary and alternative supplement use in individuals with chronic heart failure. J Card Fail. 2005, 11: 586-589.","journal-title":"J Card Fail"},{"key":"45_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jacc.2009.07.074","volume":"55","author":"A Tachjian","year":"2010","unstructured":"Tachjian A, Maria V, Jahangir A: Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010, 55: 515-525.","journal-title":"J Am Coll Cardiol"},{"key":"45_CR9","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1001\/archinte.158.20.2225","volume":"158","author":"NH Mashour","year":"1998","unstructured":"Mashour NH, Lin GI, Frishman WH: Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Arch Intern Med. 1998, 158: 2225-2234.","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"45_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2165\/11534650-000000000-00000","volume":"26","author":"C Maraldi","year":"2009","unstructured":"Maraldi C, Lattanzio F, Onder G, Gallerani M, Bustacchini S, De TG, Volpato S: Variability in the prescription of cardiovascular medications in older patients: correlates and potential explanations. Drugs Aging. 2009, 26 (Suppl 1): 41-51.","journal-title":"Drugs Aging"},{"key":"45_CR11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.amjcard.2009.12.077","volume":"105","author":"JB Garner","year":"2010","unstructured":"Garner JB: Problems of nonadherence in cardiology and proposals to improve outcomes. Am J Cardiol. 2010, 105: 1495-1501.","journal-title":"Am J Cardiol"},{"key":"45_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ahj.2003.10.021","volume":"147","author":"KL Miller","year":"2004","unstructured":"Miller KL, Liebowitz RS, Newby LK: Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches. Am Heart J. 2004, 147: 401-411.","journal-title":"Am Heart J"},{"key":"45_CR13","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.2174\/138920008786927785","volume":"9","author":"C Ulbricht","year":"2008","unstructured":"Ulbricht C, Chao W, Costa D, Rusie-Seamon E, Weissner W, Woods J: Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration. Curr Drug Metab. 2008, 9: 1063-1120.","journal-title":"Curr Drug Metab"},{"key":"45_CR14","unstructured":"The Agency for Healthcare Research and Quality.http:\/\/www.effectivehealthcare.ahrq.gov\/index.cfm,"},{"key":"45_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1745-6215-10-46","volume":"10","author":"T Wu","year":"2009","unstructured":"Wu T, Li Y, Bian Z, Liu G, Moher D: Randomized trials published in some Chinese journals: how many are randomized?. Trials. 2009, 10: 46-","journal-title":"Trials"},{"key":"45_CR16","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.7326\/0003-4819-142-12_Part_2-200506211-00003","volume":"142","author":"PG Shekelle","year":"2005","unstructured":"Shekelle PG, Morton SC, Suttorp MJ, Buscemi N, Friesen C: Challenges in systematic reviews of complementary and alternative medicine topics. Ann Intern Med. 2005, 142: 1042-1047.","journal-title":"Ann Intern Med"},{"key":"45_CR17","doi-asserted-by":"crossref","first-page":"1001S","DOI":"10.1093\/ajcn\/77.4.1001S","volume":"77","author":"CH Halsted","year":"2003","unstructured":"Halsted CH: Dietary supplements and functional foods: 2 sides of a coin?. Am J Clin Nutr. 2003, 77: 1001S-1007S.","journal-title":"Am J Clin Nutr"},{"key":"45_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tox.2005.12.022","volume":"221","author":"P Coppens","year":"2006","unstructured":"Coppens P, da Silva MF, Pettman S: European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety. Toxicology. 2006, 221: 59-74.","journal-title":"Toxicology"},{"key":"45_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1017\/S0029665107005824","volume":"66","author":"C Eberhardie","year":"2007","unstructured":"Eberhardie C: Nutritional supplements and the EU: is anyone happy?. Proc Nutr Soc. 2007, 66: 508-511.","journal-title":"Proc Nutr Soc"},{"key":"45_CR20","unstructured":"US Food and Drug Administration: Overview of Dietary Supplements.http:\/\/www.fda.gov\/food\/dietarysupplements\/consumerinformation\/ucm110417.htm,"},{"key":"45_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1345\/aph.1C163","volume":"37","author":"C Pharand","year":"2003","unstructured":"Pharand C, Ackman ML, Jackevicius CA, Paradiso-Hardy FL, Pearson GJ: Canadian Cardiovascular Pharmacists Network: Use of OTC and herbal products in patients with cardiovascular disease. Ann Pharmacother. 2003, 37: 899-904.","journal-title":"Ann Pharmacother"},{"key":"45_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6882-8-4","volume":"8","author":"F Gohar","year":"2008","unstructured":"Gohar F, Greenfield SM, Gareth BD, Lip GYH, Jolly K: Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med. 2008, 8: 4-","journal-title":"BMC Complement Altern Med"},{"key":"45_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1001\/archfami.9.3.258","volume":"9","author":"LS Balluz","year":"2000","unstructured":"Balluz LS, Kieszak SM, Philen RM, Mulinare J: Vitamin and mineral supplement use in the United States: results from the third national health and nutrition examination survey. Arch Fam Med. 2000, 9: 258-262.","journal-title":"Arch Fam Med"},{"key":"45_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s003940050017","volume":"37","author":"B Schellhorn","year":"1998","unstructured":"Schellhorn B, Doring A, Stieber J: Use of vitamin and mineral supplements: Results from the survey 1994\/95 of the WHO MONICA Project Augsburg. Z Ern\u00e4hrungswiss. 1998, 37: 198-206.","journal-title":"Z Ern\u00e4hrungswiss"},{"key":"45_CR25","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/j.1532-5415.2009.02329.x","volume":"57","author":"RL Nahin","year":"2009","unstructured":"Nahin RL, Pecha M, Welmerink DB, Sink K, DeKosky ST, Fitzpatrick AL: Ginkgo Evaluation of Memory Study Investigators: Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people. J Am Geriatr Soc. 2009, 57: 1197-1205.","journal-title":"J Am Geriatr Soc"},{"key":"45_CR26","first-page":"1","volume":"2008","author":"PM Barnes","year":"2007","unstructured":"Barnes PM, Bloom B, Nahin RL: Complementary and alternative medicine use among adults and children: United States. Natl Health Stat Report. 2007, 2008: 1-23.","journal-title":"Natl Health Stat Report"},{"key":"45_CR27","first-page":"227","volume":"110","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circ Cardiovasc Qual Outcomes. 2004, 110: 227-239.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"45_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jclinepi.2009.03.009","volume":"63","author":"DK Owens","year":"2010","unstructured":"Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, Chang S, Helfand M: AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions\u2013agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol. 2010, 63: 513-523.","journal-title":"J Clin Epidemiol"},{"key":"45_CR29","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jclinepi.2010.11.021","volume":"64","author":"D Atkins","year":"2011","unstructured":"Atkins D, Chang SM, Gartlehner G, Buckley DI, Whitlock EP, Berliner E, Matchar D: Assessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program. J Clin Epidemiol. 2011, 64: 1198-1207.","journal-title":"J Clin Epidemiol"},{"key":"45_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 177-188.","journal-title":"Control Clin Trials"},{"issue":"11","key":"45_CR31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jclinepi.2010.08.010","volume":"64","author":"R Fu","year":"2011","unstructured":"Fu R, Gartlehner G, Grant M, Shamliyan T, Sedrakyan A, Wilt TJ, Griffith L, Oremus M, Raina P, Ismaila A, Santaguida P, Lau J, Trikalinos TA: Conducting quantitative synthesis when comparing medical interventions: AHRQ and the effective health care program. J Clin Epidemiol. 2011, 64 (11): 1187-1197.","journal-title":"J Clin Epidemiol"},{"key":"45_CR32","volume-title":"Approved drug products with therapeutic equivalence evaluations","author":"US Food and Drugs Administration","year":"2011","unstructured":"US Food and Drugs Administration: Approved drug products with therapeutic equivalence evaluations. 2011, Silver Spring (MD): US Food and Drug Administration"},{"key":"45_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2165\/00002018-200225050-00005","volume":"25","author":"B Takkouche","year":"2002","unstructured":"Takkouche B, Etminan M, Caamano F, Rochon PA: Interaction between aspirin and ACE Inhibitors: resolving discrepancies using a meta-analysis. Drug Saf. 2002, 25: 373-378.","journal-title":"Drug Saf"},{"key":"45_CR34","unstructured":"The Agency for Healthcare Research and Quality: Available at: http:\/\/www.effectivehealthcare.ahrq.gov\/index.cfm. Last Accessed: 8-3-2012"},{"key":"45_CR35","volume-title":"Comprehensive meta analysis","author":"M Borenstein","year":"2005","unstructured":"Borenstein M, Hedges L, Higgins J, Rothstein H: Comprehensive meta analysis. 2005, Englewood NJ, Version 2.2.057"},{"key":"45_CR36","volume-title":"StatsDirect statistical software","author":"StatsDirect Ltd","year":"2012","unstructured":"StatsDirect Ltd: StatsDirect statistical software. 2012, UK: Altrincham"},{"key":"45_CR37","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1517\/14656560802233827","volume":"9","author":"M Di Spirito","year":"2008","unstructured":"Di Spirito M, Morelli G, Doyle RT, Johnson J, McKenney J: Effect of omega-3-acid ethyl esters on steady-state plasma pharmacokinetics of atorvastatin in healthy adults. Expert Opin Pharmacother. 2008, 9: 2939-2945.","journal-title":"Expert Opin Pharmacother"},{"key":"45_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.amjcard.2008.03.078","volume":"102","author":"KC Maki","year":"2008","unstructured":"Maki KC, McKenney JM, Reeves MS, Lubin BC, Dicklin MR: Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg\/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia. Am J Cardiol. 2008, 102: 429-433. Erratum appears inAm J Cardiol2008; 102(10):1425.","journal-title":"Am J Cardiol"},{"key":"45_CR39","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.amjcard.2007.06.030","volume":"100","author":"JM Young","year":"2007","unstructured":"Young JM, Florkowski CM, Molyneux SL, McEwan RG, Frampton CM, George PM, Scott RS: Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol. 2007, 100: 1400-1403.","journal-title":"Am J Cardiol"},{"key":"45_CR40","first-page":"1497","volume":"116","author":"RJ Glynn","year":"2007","unstructured":"Glynn RJ, Ridker PM, Goldhaber SZ, Zee RY, Buring JE: Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circ Cardiovasc Qual Outcomes. 2007, 116: 1497-1503.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"45_CR41","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.clinthera.2007.07.018","volume":"29","author":"MH Davidson","year":"2007","unstructured":"Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN: COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators: Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g\/d to simvastatin 40 mg\/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2007, 29: 1354-1367.","journal-title":"Clin Ther"},{"key":"45_CR42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.thromres.2004.03.016","volume":"113","author":"S Miyamoto","year":"2004","unstructured":"Miyamoto S, Kawano H, Takazoe K, Soejima H, Sakamoto T, Hokamaki J, Yoshimura M, Nakamura H, Yodoi J, Ogawa H: Vitamin E improves fibrinolytic activity in patients with coronary spastic angina. Thromb Res. 2004, 113: 345-351.","journal-title":"Thromb Res"},{"key":"45_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1046\/j.1365-2362.2002.01001.x","volume":"32","author":"DC Chan","year":"2002","unstructured":"Chan DC, Watts GF, Mori TA, Barrett PH, Beilin LJ, Redgrave TG: Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity. Eur J Clin Invest. 2002, 32: 429-436.","journal-title":"Eur J Clin Invest"},{"key":"45_CR44","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0735-1097(98)00447-1","volume":"32","author":"T Motoyama","year":"1998","unstructured":"Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, Moriyama Y, Miyao Y, Yoshimura M, Ogawa H, Yasue H: Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol. 1998, 32: 1672-1679.","journal-title":"J Am Coll Cardiol"},{"key":"45_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00019501-199809050-00003","volume":"9","author":"C Napoli","year":"1998","unstructured":"Napoli C, Leccese M, Palumbo G, De NF, Chiariello P, Zuliani P, Somma P, Di LM, De MC, Cacciatore F, Abete P, Liguori A, Chiariello M, D'Armiento FP: Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia. Coron Artery Dis. 1998, 9: 257-264.","journal-title":"Coron Artery Dis"},{"key":"45_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0002-9149(97)89130-8","volume":"77","author":"J Eritsland","year":"1996","unstructured":"Eritsland J, Arnesen H, Nseth K, Fjeld NB, Abdelnoor M: Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol. 1996, 77: 31-36.","journal-title":"Am J Cardiol"},{"key":"45_CR47","first-page":"760","volume":"43","author":"RK Garg","year":"1995","unstructured":"Garg RK, Nag D, Agrawal A: A double blind placebo controlled trial of ginkgo biloba extract in acute cerebral ischaemia. J Assoc Phys India. 1995, 43: 760-763.","journal-title":"J Assoc Phys India"},{"key":"45_CR48","doi-asserted-by":"crossref","first-page":"1381S","DOI":"10.1093\/ajcn\/62.6.1381S","volume":"62","author":"M Steiner","year":"1995","unstructured":"Steiner M, Glantz M, Lekos A: Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. Am J Clin Nutr. 1995, 62: 1381S-1384S.","journal-title":"Am J Clin Nutr"},{"key":"45_CR49","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1253\/jcj.59.608","volume":"59","author":"H Yamamoto","year":"1995","unstructured":"Yamamoto H, Yoshimura H, Noma M, Suzuki S, Kai H, Tajimi T, Sugihara M, Kikuchi Y: Improvement of coronary vasomotion with eicosapentaenoic acid does not inhibit acetylcholine-induced coronary vasospasm in patients with variant angina. Jpn Circ J. 1995, 59: 608-616. Erratum appears inJpn Circ J1995, 59(11):773\u2013774.","journal-title":"Jpn Circ J"},{"key":"45_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0167-5273(92)90059-C","volume":"35","author":"U Kaul","year":"1992","unstructured":"Kaul U, Sanghvi S, Bahl VK, Dev V, Wasir HS: Fish oil supplements for prevention of restenosis after coronary angioplasty. Int J Cardiol. 1992, 35: 87-93.","journal-title":"Int J Cardiol"},{"key":"45_CR51","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJM198809223191201","volume":"319","author":"GJ Dehmer","year":"1988","unstructured":"Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Prewitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM: Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med. 1988, 319: 733-740.","journal-title":"N Engl J Med"},{"key":"45_CR52","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0271-5317(03)00102-7","volume":"23","author":"M Liu","year":"2003","unstructured":"Liu M, Wallmon A, Wallin R, Saldeen T: Effects of stable fish oil and simvastatin on plasma lipoproteins in patients with hyperlipidemia. Nutr Res. 2003, 23: 1027-1034.","journal-title":"Nutr Res"},{"key":"45_CR53","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0735-1097(99)00064-9","volume":"33","author":"PS Watson","year":"1999","unstructured":"Watson PS, Scalia GM, Galbraith A, Burstow DJ, Bett N, Aroney CN: Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol. 1999, 33: 1549-1552.","journal-title":"J Am Coll Cardiol"},{"key":"45_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1023\/A:1008852127668","volume":"5","author":"NK Bender","year":"1998","unstructured":"Bender NK, Kraynak MA, Chiquette E, Linn WD, Clark GM, Bussey HI: Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy. J Thromb Thrombolysis. 1998, 5: 257-261.","journal-title":"J Thromb Thrombolysis"},{"key":"45_CR55","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/FJC.0b013e3181b0cf71","volume":"54","author":"EM Roth","year":"2009","unstructured":"Roth EM, Bays HE, Forker AD, Maki KC, Carter R, Doyle RT, Stein EA: Prescription omega-3 fatty acid as an adjunct to fenofibrate therapy in hypertriglyceridemic subjects. J Cardiovasc Pharmacol. 2009, 54: 196-203.","journal-title":"J Cardiovasc Pharmacol"},{"key":"45_CR56","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0021-9150(02)00417-3","volume":"168","author":"DA Playford","year":"2003","unstructured":"Playford DA, Watts GF, Croft KD, Burke V: Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes. Atherosclerosis. 2003, 168: 169-179.","journal-title":"Atherosclerosis"},{"key":"45_CR57","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1016\/j.atherosclerosis.2007.06.010","volume":"195","author":"H Mabuchi","year":"2007","unstructured":"Mabuchi H, Nohara A, Kobayashi J, Kawashiri MA, Katsuda S, Inazu A, Koizumi J, Hokuriku Lipid Research Group: Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. Atherosclerosis. 2007, 195: e182-e189.","journal-title":"Atherosclerosis"},{"key":"45_CR58","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","volume":"99","author":"G Caso","year":"2007","unstructured":"Caso G, Kelly P, McNurlan MA, Lawson WE: Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. Am J Cardiol. 2007, 99: 1409-1412.","journal-title":"Am J Cardiol"},{"key":"45_CR59","doi-asserted-by":"crossref","first-page":"793S","DOI":"10.1093\/jn\/136.3.793S","volume":"136","author":"H Macan","year":"2006","unstructured":"Macan H, Uykimpang R, Alconcel M, Takasu J, Razon R, Amagase H, Niihara Y: Aged garlic extract may be safe for patients on warfarin therapy. J Nutr. 2006, 136: 793S-795S.","journal-title":"J Nutr"},{"key":"45_CR60","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/bjp.2008.210","volume":"154","author":"MI Mohammed Abdul","year":"2008","unstructured":"Mohammed Abdul MI, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, McLachlan AJ: Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol. 2008, 154: 1691-1700.","journal-title":"Br J Pharmacol"},{"key":"45_CR61","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0952-3278(98)90034-5","volume":"58","author":"A Bordia","year":"1998","unstructured":"Bordia A, Verma SK, Srivastava KC: Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids. 1998, 58: 257-263.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"45_CR62","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ypmed.2004.04.012","volume":"39","author":"MJ Budoff","year":"2004","unstructured":"Budoff MJ, Takasu J, Flores FR, Niihara Y, Lu B, Lau BH, Rosen RT, Amagase H: Inhibiting progression of coronary calcification using Aged Garlic Extract in patients receiving statin therapy: a preliminary study. Prev Med. 2004, 39: 985-991.","journal-title":"Prev Med"},{"key":"45_CR63","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1365-2125.2005.02322.x","volume":"59","author":"X Jiang","year":"2005","unstructured":"Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ: Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2005, 59: 425-432.","journal-title":"Br J Clin Pharmacol"},{"key":"45_CR64","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2165\/00126839-200607030-00003","volume":"7","author":"HR Wolf","year":"2006","unstructured":"Wolf HR: DoesGinkgo bilobaspecial extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500\u2009mg daily?. Drugs in R D. 2006, 7: 163-172.","journal-title":"Drugs in R D"},{"key":"45_CR65","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/MBC.0b013e3282f102b1","volume":"18","author":"CD Gardner","year":"2007","unstructured":"Gardner CD, Zehnder JL, Rigby AJ, Nicholus JR, Farquhar JW: Effect ofGinkgo biloba(EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. Blood Coagul Fibrinolysis. 2007, 18: 787-793.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"45_CR66","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.clinthera.2010.01.027","volume":"32","author":"BH Kim","year":"2010","unstructured":"Kim BH, Kim KP, Lim KS, Kim JR, Yoon SH, Cho JY, Lee YO, Lee KH, Jang IJ, Shin SG, Yu KS: Influence ofGinkgo bilobaextract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers. Clin Ther. 2010, 32: 380-390.","journal-title":"Clin Ther"},{"key":"45_CR67","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2125.2006.02759.x","volume":"63","author":"D Aruna","year":"2007","unstructured":"Aruna D, Naidu MU: Pharmacodynamic interaction studies ofGinkgo bilobawith cilostazol and clopidogrel in healthy human subjects. Br J Clin Pharmacol. 2007, 63: 333-338.","journal-title":"Br J Clin Pharmacol"},{"key":"45_CR68","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1089\/acm.2007.0799","volume":"14","author":"SH Lee","year":"2008","unstructured":"Lee SH, Ahn YM, Ahn SY, Doo HK, Lee BC: Interaction between warfarin andPanax ginsengin ischemic stroke patients. J Altern Complement Med. 2008, 14: 715-721.","journal-title":"J Altern Complement Med"},{"key":"45_CR69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.7326\/0003-4819-141-1-200407060-00011","volume":"141","author":"CS Yuan","year":"2004","unstructured":"Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, Kasza K, Ang-Lee M, Moss J: Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial. Ann Intern Med. 2004, 141: 23-27.","journal-title":"Ann Intern Med"},{"key":"45_CR70","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1365-2125.2003.02051.x","volume":"57","author":"X Jiang","year":"2004","unstructured":"Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ: Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2004, 57: 592-599. [Erratum appears in Br J Clin Pharmacol 2004, 58(1):102","journal-title":"Br J Clin Pharmacol"},{"key":"45_CR71","first-page":"637","volume":"43","author":"R Tankanow","year":"2003","unstructured":"Tankanow R, Tamer HR, Streetman DS, Smith SG, Welton JL, Annesley T, Aaronson KD, Bleske BE: Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol. 2003, 43: 637-642.","journal-title":"J Clin Pharmacol"},{"key":"45_CR72","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4065\/mcp.2009.0397","volume":"85","author":"HE Bays","year":"2010","unstructured":"Bays HE, McKenney J, Maki KC, Doyle RT, Carter RN, Stein E: Effects of prescription omega-3-acid ethyl esters on non\u2013high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin. Mayo Clin Proc. 2010, 85: 122-128.","journal-title":"Mayo Clin Proc"},{"key":"45_CR73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1161\/01.ATV.20.1.259","volume":"20","author":"A Nord\u00f8y","year":"2000","unstructured":"Nord\u00f8y A, Bonaa KH, Sandset PM, Hansen JB, Nilsen H: Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia. Arterioscler Thromb Vasc Biol. 2000, 20: 259-265.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"45_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11745-006-3014-4","volume":"42","author":"BJ Meyer","year":"2007","unstructured":"Meyer BJ, Hammervold T, Rustan AC, Howe PR: Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects. Lipids. 2007, 42: 109-115.","journal-title":"Lipids"},{"key":"45_CR75","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0002-9149(97)00522-5","volume":"80","author":"MH Davidson","year":"1997","unstructured":"Davidson MH, Macariola-Coad JR, McDonald AM, Maki KC, Hall HA: Separate and joint effects of marine oil and simvastatin in patients with combined hyperlipidemia. Am J Cardiol. 1997, 80: 797-798.","journal-title":"Am J Cardiol"},{"key":"45_CR76","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1046\/j.1538-7836.2003.00140.x","volume":"1","author":"A Nord\u00f8y","year":"2003","unstructured":"Nord\u00f8y A, Svensson B, Hansen JB: Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia. J Thromb Haemost. 2003, 1: 690-697.","journal-title":"J Thromb Haemost"},{"key":"45_CR77","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jacl.2007.05.002","volume":"1","author":"WL Isley","year":"2007","unstructured":"Isley WL, Miles JM, Harris WS: Pilot study of combined therapy with omega-3 fatty acids and niacin in atherogenic dyslipidemia. J Clin Lipidol. 2007, 1: 211-217.","journal-title":"J Clin Lipidol"},{"key":"45_CR78","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/ndt\/gfn454","volume":"24","author":"PM Ferraro","year":"2009","unstructured":"Ferraro PM, Ferraccioli GF, Gambaro G, Fulignati P, Costanzi S: Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial. Nephrol Dial Transplant. 2009, 24: 156-160.","journal-title":"Nephrol Dial Transplant"},{"key":"45_CR79","first-page":"43","volume":"8","author":"PR Howe","year":"1994","unstructured":"Howe PR, Lungershausen YK, Cobiac L, Dandy G, Nestel PJ: Effect of sodium restriction and fish oil supplementation on BP and thrombotic risk factors in patients treated with ACE inhibitors. J Hum Hypertens. 1994, 8: 43-49.","journal-title":"J Hum Hypertens"},{"key":"45_CR80","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0049-3848(02)00010-5","volume":"105","author":"N Svaneborg","year":"2002","unstructured":"Svaneborg N, Kristensen SD, Hansen LM, Llow I, Husted SE, Schmidt EB: The acute and short-time effect of supplementation with the combination of n-3 fatty acids and acetylsalicylic acid on platelet function and plasma lipids. Thromb Res. 2002, 105: 311-316.","journal-title":"Thromb Res"},{"key":"45_CR81","first-page":"102","volume":"87","author":"GP Balestrieri","year":"1996","unstructured":"Balestrieri GP, Maffi V, Sleiman I, Spandrio S, Di SO, Salvi A, Scalvini T: Fish oil supplementation in patients with heterozygous familial hypercholesterolemia. Recenti Prog Med. 1996, 87: 102-105.","journal-title":"Recenti Prog Med"},{"key":"45_CR82","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/01.ATV.13.1.98","volume":"13","author":"JB Hansen","year":"1993","unstructured":"Hansen JB, Lyngmo V, Svensson B, Nord YA: Inhibition of exercise-induced shortening of bleeding time by fish oil in familial hypercholesterolemia (type IIa). Rterioscler Thromb. 1993, 13: 98-104.","journal-title":"Rterioscler Thromb"},{"key":"45_CR83","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/0091270006289849","volume":"46","author":"JM McKenney","year":"2006","unstructured":"McKenney JM, Swearingen D, Di SM, Doyle R, Pantaleon C, Kling D, Shalwitz RA: Study of the pharmacokinetic interaction between simvastatin and prescription omega-3-acid ethyl esters. J Clin Pharmacol. 2006, 46: 785-791.","journal-title":"J Clin Pharmacol"},{"key":"45_CR84","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/j.1552-4604.1991.tb03706.x","volume":"31","author":"BA Mueller","year":"1991","unstructured":"Mueller BA, Talbert RL, Tegeler CH, Prihoda TJ: The bleeding time effects of a single dose of aspirin in subjects receiving omega-3 fatty acid dietary supplementation. J Clin Pharmacol. 1991, 31: 185-190.","journal-title":"J Clin Pharmacol"},{"key":"45_CR85","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/ajh\/7.12.1115","volume":"7","author":"YK Lungershausen","year":"1994","unstructured":"Lungershausen YK, Howe PR: Improved detection of a blood pressure response to dietary intervention with 24-hour ambulatory monitoring. Am J Hypertens. 1994, 7: 1115-1117.","journal-title":"Am J Hypertens"},{"key":"45_CR86","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/01.ATV.0000104028.07929.72","volume":"24","author":"F Micheletta","year":"2004","unstructured":"Micheletta F, Natoli S, Misuraca M, Sbarigia E, Diczfalusy U, Iuliano L: Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque. Arterioscler Thromb Vasc Biol. 2004, 24: 136-140.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"45_CR87","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/01.HYP.34.4.1002","volume":"34","author":"M Barbagallo","year":"1999","unstructured":"Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G: Effects of vitamin E and glutathione on glucose metabolism: role of magnesium. Hypertension. 1999, 34: 1002-1006.","journal-title":"Hypertension"},{"key":"45_CR88","first-page":"453","volume":"27","author":"E Sutken","year":"2006","unstructured":"Sutken E, Inal M, Ozdemir F: Effects of vitamin E and gemfibrozil on lipid profiles, lipid peroxidation and antioxidant status in the elderly and young hyperlipidemic subjects. Saudi Med J. 2006, 27: 453-459.","journal-title":"Saudi Med J"},{"key":"45_CR89","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1210\/jc.2003-030724","volume":"88","author":"G Desideri","year":"2003","unstructured":"Desideri G, Croce G, Tucci M, Passacquale G, Broccoletti S, Valeri L, Santucci A, Ferri C: Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. J Clin Endocrinol Metab. 2003, 88: 5341-5347.","journal-title":"J Clin Endocrinol Metab"},{"key":"45_CR90","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2004.04.005","volume":"175","author":"YK Manuel","year":"2004","unstructured":"Manuel YK, Vinckx M, Vertommen J, Van GL, De Leeuw I: Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin. Atherosclerosis. 2004, 175: 369-376.","journal-title":"Atherosclerosis"},{"key":"45_CR91","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1046\/j.1440-1681.2001.03458.x","volume":"28","author":"SJ Duffy","year":"2001","unstructured":"Duffy SJ, O'Brien RC, New G, Harper RW, Meredith IT: Effect of anti-oxidant treatment and cholesterol lowering on resting arterial tone, metabolic vasodilation and endothelial function in the human forearm: a randomized, placebo-controlled study. Clin Exp Pharmacol Physiol. 2001, 28: 409-418.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"45_CR92","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1365-2362.1994.tb01073.x","volume":"24","author":"IF McDowell","year":"1994","unstructured":"McDowell IF, Brennan GM, McEneny J, Young IS, Nicholls DP, McVeigh GE, Bruce I, Trimble ER, Johnston GD: The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans. Eur J Clin Invest. 1994, 24: 759-765.","journal-title":"Eur J Clin Invest"},{"key":"45_CR93","first-page":"2543","volume":"106","author":"R De Caterina","year":"2002","unstructured":"De Caterina R, Cipollone F, Filardo FP, Zimarino M, Bernini W, Lazzerini G, Bucciarelli T, Falco A, Marchesani P, Muraro R, Mezzetti A, Ciabattoni G: Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. Circ Cardiovasc Qual Outcomes. 2002, 106: 2543-2549.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"45_CR94","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/ajcn\/61.4.848","volume":"61","author":"G Paolisso","year":"1995","unstructured":"Paolisso G, Gambardella A, Giugliano D, Galzerano D, Amato L, Volpe C, Balbi V, Varricchio M, D'Onofrio F: Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease. Am J Clin Nutr. 1995, 61: 848-852.","journal-title":"Am J Clin Nutr"},{"key":"45_CR95","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.contraception.2004.05.012","volume":"70","author":"C D'Arcangues","year":"2004","unstructured":"D'Arcangues C, Piaggio G, Brache V, Aissa RB, Hazelden C, Massai R, Pinol A, Subakir SB, Su-juan G, Study Group on Progestogen-induced Vaginal Bleeding Disturbances: Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding. Contraception. 2004, 70: 451-462.","journal-title":"Contraception"},{"key":"45_CR96","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1517\/14656560802532640","volume":"9","author":"P Gosai","year":"2008","unstructured":"Gosai P, Liu J, Doyle RT, Johnson J, Carter R, Sica D, McKenney JM: Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of rosuvastatin in healthy adults. Expert Opin Pharmacother. 2008, 9: 2947-2953.","journal-title":"Expert Opin Pharmacother"},{"key":"45_CR97","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-2125.2010.03620.x","volume":"69","author":"MI Abdul","year":"2010","unstructured":"Abdul MI, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, Matthias A, Lehmann RP, McLachlan AJ: Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects. Br J Clin Pharmacol. 2010, 69: 508-515.","journal-title":"Br J Clin Pharmacol"},{"key":"45_CR98","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00045391-200307000-00003","volume":"10","author":"VF Mauro","year":"2003","unstructured":"Mauro VF, Mauro LS, Kleshinski JF, Khuder SA, Wang Y, Erhardt PW: Impact ofGinkgo bilobaon the pharmacokinetics of digoxin. Am J Ther. 2003, 10: 247-251.","journal-title":"Am J Ther"},{"key":"45_CR99","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.amjcard.2009.05.055","volume":"104","author":"PD Watson","year":"2009","unstructured":"Watson PD, Joy PS, Nkonde C, Hessen SE, Karalis DG: Comparison of bleeding complications with omega-3 fatty acids\u2009+\u2009aspirin\u2009+\u2009clopidogrel\u2013versus\u2013aspirin\u2009+\u2009clopidogrel in patients with cardiovascular disease. Am J Cardiol. 2009, 104: 1052-1054.","journal-title":"Am J Cardiol"},{"key":"45_CR100","volume-title":"Dietary supplements in adults taking cardiovascular drugs","author":"D Seely","year":"2012","unstructured":"Seely D, Kanji S, Yazdi F, Tetzlaff J, Singh K, Tsertsvadze A, Sears M, Tricco A, Ooi TC, Turek M, Tsouros S, Skidmore B, Daniel R, Ansari M: Dietary supplements in adults taking cardiovascular drugs. 2012, Rockville, MD: Agency for Healthcare Research and Quality, Publication No.12-EHC021-EF"},{"key":"45_CR101","volume-title":"R: a language and environment for statistical computing","author":"Foundation for Statistical Computing","year":"2011","unstructured":"Foundation for Statistical Computing: R: a language and environment for statistical computing. 2011, Vienna, Austria"},{"key":"45_CR102","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ejps.2010.09.016","volume":"41","author":"J Hajda","year":"2010","unstructured":"Hajda J, Rentsch KM, Gubler C, Steinert H, Stieger B, Fattinger K: Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans. Eur J Pharm Sci. 2010, 41: 729-735.","journal-title":"Eur J Pharm Sci"},{"key":"45_CR103","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.atherosclerosis.2010.09.013","volume":"213","author":"HA Neil","year":"2010","unstructured":"Neil HA, Ceglarek U, Thiery J, Paul S, Farmer A, Holman RR: Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial. Atherosclerosis. 2010, 213: 512-517.","journal-title":"Atherosclerosis"},{"key":"45_CR104","unstructured":"FDA should take further actions to improve oversight and consumer understanding.http:\/\/www.gao.gov\/products\/GAO-09-250,"},{"key":"45_CR105","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/01.ftd.0000170880.95267.90","volume":"27","author":"E Mills","year":"2005","unstructured":"Mills E, Wu P, Johnston BC, Gallicano K, Clarke M, Guyatt G: Natural health product-drug interactions: A systematic review of clinical trials. Ther Drug Monit. 2005, 27: 549-557.","journal-title":"Ther Drug Monit"},{"key":"45_CR106","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.thromres.2005.06.017","volume":"117","author":"D Desai","year":"2005","unstructured":"Desai D, Hasan A, Wesley R, Sunderland E, Pucino F, Csako G: Effects of dietary supplements on aspirin and other antiplatelet agents: an evidence-based approach. Thromb Res. 2005, 117: 87-101.","journal-title":"Thromb Res"},{"key":"45_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2003.06.039","volume":"98","author":"AA Izzo","year":"2005","unstructured":"Izzo AA, Di Carlo G, Borrelli F, Ernst E: Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol. 2005, 98: 1-14.","journal-title":"Int J Cardiol"},{"key":"45_CR108","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/FTD.0b013e31815c17f6","volume":"29","author":"S Skalli","year":"2007","unstructured":"Skalli S, Zaid A, Soulaymani R: Drug interactions with herbal medicines. Ther Drug Monit. 2007, 29: 679-686.","journal-title":"Ther Drug Monit"},{"key":"45_CR109","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1517\/14740330903405593","volume":"9","author":"DA Kennedy","year":"2010","unstructured":"Kennedy DA, Seely D: Clinically based evidence of drug-herb interactions: a systematic review. Expert Opin Drug Saf. 2010, 9: 79-124.","journal-title":"Expert Opin Drug Saf"},{"key":"45_CR110","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","volume":"350","author":"M Egger","year":"1997","unstructured":"Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G: Language bias in randomised controlled trials published in English and German. Lancet. 1997, 350: 326-329.","journal-title":"Lancet"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-1-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2046-4053-1-26\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-1-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-1-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:17:50Z","timestamp":1630531070000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/2046-4053-1-26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,31]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["45"],"URL":"https:\/\/doi.org\/10.1186\/2046-4053-1-26","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,31]]},"assertion":[{"value":"6 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"26"}}